FIELD: electricity.
SUBSTANCE: invention relates to an activating device with an automatic circuit breaker unit for a dual battery system that includes a system of power batteries, which is connected to an electrical system containing a starter motor and a circuit of an ignition switch for a transport vehicle, and a system of starter batteries, which can be connected parallel to the system of power batteries by means of the automatic circuit breaker unit that can be switched between an open state and a closed state; when in the latter state, the system of starter batteries is able to supply energy to the electrical system. The activating device includes a control unit, a signal block having a possibility of generating voltage signal yi and supplying voltage signal y to the ignition switch circuit, a monitoring unit having a possibility of monitoring voltage signal y from connection of the ignition switch and a possibility of generation of a monitoring signal based on a controlled voltage signal y, and a processor unit having a possibility of comparing the monitoring signal to a pre-set detection criterion and a possibility of generation of a control signal based on this comparison, which is transmitted to the control unit. The invention also includes an activation method of an automatic circuit breaker unit in a dual battery system.
EFFECT: improving device activation reliability.
14 cl, 5 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR REDUCING AND/OR REMOVING FXI AND FXIA FROM SOLUTIONS CONTAINING SAID CLOTTING FACTORS | 2011 |
|
RU2649363C2 |
PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED THROMBOGENIC AGENT CONTENT, AND IMMUNOGLOBULIN COMPOSITION | 2012 |
|
RU2627162C2 |
PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2739946C2 |
NOVEL HUMANISED ANTIBODIES TO FACTOR XI WITH ANTITHROMBOTIC AND ANTI-INFLAMMATORY ACTION AND USE THEREOF | 2020 |
|
RU2817219C2 |
METHOD OF ALPHA-1-ANTITRYPSIN SOLUTION TREATMENT | 2004 |
|
RU2370500C2 |
METHOD OF SEPARATING AND PURIFYING TARGET PROTEIN WITHOUT ADMIXTURE OF PRION PROTEIN PrP | 2008 |
|
RU2491292C2 |
METHOD OF PURIFYING VITAMIN K-DEPENDENT PROTEINS, SUCH AS COAGULATION FACTOR VII | 2011 |
|
RU2731720C2 |
METHOD FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IX | 2011 |
|
RU2590726C2 |
METHOD FOR PRODUCING A HIGHLY PURIFIED RECOMBINANT HUMAN C1-ESTERASE INHIBITOR FOR APPLICATION IN MEDICINE | 2020 |
|
RU2769201C2 |
Authors
Dates
2014-12-20—Published
2011-10-18—Filed